These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26115542)

  • 21. Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.
    Laguna TA; Wagner BD; Starcher B; Luckey Tarro HK; Mann SA; Sagel SD; Accurso FJ
    Pediatr Pulmonol; 2012 Sep; 47(9):856-63. PubMed ID: 22431382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased physical activity post-exacerbation is associated with decreased systemic inflammation in cystic fibrosis - An observational study.
    Burton K; Morris NR; Reid D; Smith D; Kuys S
    Physiother Theory Pract; 2020 Dec; 36(12):1457-1465. PubMed ID: 30686137
    [No Abstract]   [Full Text] [Related]  

  • 23. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
    Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dried Blood Spot-Based Metabolomic Profiling in Adults with Cystic Fibrosis.
    Al-Qahtani W; Abdel Jabar M; Masood A; Jacob M; Nizami I; Dasouki M; Abdel Rahman AM
    J Proteome Res; 2020 Jun; 19(6):2346-2357. PubMed ID: 32312052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic duration and changes in FEV
    Espel JC; Palac HL; Cullina JF; Clarke AP; McColley SA; Prickett MH; Jain M
    BMC Pulm Med; 2017 Nov; 17(1):160. PubMed ID: 29187171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation.
    Muhlebach MS; Sha W; MacIntosh B; Kelley TJ; Muenzer J
    Metabol Open; 2019 Sep; 3():100010. PubMed ID: 32812947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis.
    O'Connor JB; Mottlowitz M; Kruk ME; Mickelson A; Wagner BD; Harris JK; Wendt CH; Laguna TA
    Front Cell Infect Microbiol; 2022; 12():805170. PubMed ID: 35360097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis.
    Quon BS; Ngan DA; Wilcox PG; Man SF; Sin DD
    PLoS One; 2014; 9(2):e89341. PubMed ID: 24586701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
    Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
    Aslam AA; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global and targeted serum metabolic profiling of colorectal cancer progression.
    Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
    Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary exacerbations, airway pathogens, and long-term course of lung clearance index in children and young adults with cystic fibrosis.
    Hatziagorou E; Avramidou V; Gioulvanidou M; Talimtzi P; Kouroukli E; Mantsiou C; Lialias I; Nousia L; Tsanakas J
    Pediatr Pulmonol; 2022 Dec; 57(12):3069-3076. PubMed ID: 36059241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation.
    Horsley AR; Davies JC; Gray RD; Macleod KA; Donovan J; Aziz ZA; Bell NJ; Rainer M; Mt-Isa S; Voase N; Dewar MH; Saunders C; Gibson JS; Parra-Leiton J; Larsen MD; Jeswiet S; Soussi S; Bakar Y; Meister MG; Tyler P; Doherty A; Hansell DM; Ashby D; Hyde SC; Gill DR; Greening AP; Porteous DJ; Innes JA; Boyd AC; Griesenbach U; Cunningham S; Alton EW
    Thorax; 2013 Jun; 68(6):532-9. PubMed ID: 23396354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAL Inflammatory Markers Can Predict Pulmonary Exacerbations in Children With Cystic Fibrosis.
    Ishak A; Stick SM; Turkovic L; Ranganathan SC; King L; Harrison J; Sly PD; Caudri D; Schultz A;
    Chest; 2020 Dec; 158(6):2314-2322. PubMed ID: 32622821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics analysis of bronchoalveolar lavage fluid predicts unique features of the lower airway in pediatric cystic fibrosis.
    O'Connor JB; Mottlowitz M; Wagner BD; Harris JK; Laguna TA
    J Cyst Fibros; 2024 Jun; ():. PubMed ID: 38853065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.
    Quinn RA; Lim YW; Mak TD; Whiteson K; Furlan M; Conrad D; Rohwer F; Dorrestein P
    PeerJ; 2016; 4():e2174. PubMed ID: 27602256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
    Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
    Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis.
    Kopp BT; Joseloff E; Goetz D; Ingram B; Heltshe SL; Leung DH; Ramsey BW; McCoy K; Borowitz D
    J Cyst Fibros; 2019 Jul; 18(4):507-515. PubMed ID: 30477895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.